Key result
High LDL-C is linked to ~20% higher ASCVD risk even with low remnant cholesterol.
Why the study?
Does elevated remnant cholesterol increase ASCVD risk in patients with elevated LDL-C?
Cohort (n=62,816)
Does elevated remnant cholesterol increase ASCVD risk in patients with elevated LDL-C?
Hazard Ratio: 1.2 (95% CI 1.02–1.41)
Absolute Event Rate: 13.2% vs 10.5%
Remnant cholesterol levels provide additional ASCVD risk stratification in patients with borderline-high LDL-C, but not in those with high LDL-C where risk remains elevated regardless of remnant cholesterol levels.
Background Low‐density lipoprotein cholesterol (LDL‐C) and remnant cholesterol (RC) are risk factors for atherosclerotic cardiovascular disease (ASCVD). However, the extent to which differences in RC levels affect ASCVD risk in populations with varying degrees of LDL‐C elevation remains unclear. This study aimed to investigate whether RC can provide additional risk stratification value across different sexes, ages, and elevated LDL‐C statuses. Methods This study included 12 743 elevated LDL‐C participants (LDL‐C ≥3.4 mmol/L) and 50 073 age‐ and sex‐matched non‐elevated LDL‐C controls from the Kailuan Study. Elevated LDL‐C participants were categorized by RC levels into <0.5, 0.5 to <1.0, and ≥1.0 mmol/L subgroups. Kaplan‐Meier curves and Cox proportional hazards models were used to assess the relationship between RC levels and ASCVD risk across different sexes, ages, and high LDL‐C statuses. Results During a median follow‐up of 12.8 years, 1686 elevated LDL‐C participants (13.2%) and 5252 non‐elevated LDL‐C participants (10.5%) developed ASCVD. In the borderline‐high LDL‐C group (3.4 ≤ LDL‐C < 4.1 mmol/L), those with the lowest RC levels showed no significant risk difference compared with controls (hazard ratio [HR], 1.03 [95% CI, 0.93–1.13]), and this pattern remained consistent across different sexes and ages. In contrast, in the high LDL‐C group (LDL‐C ≥4.1 mmol/L), even when RC was at the lowest level, ASCVD risk remained significantly higher than that of controls (HR, 1.20 [95% CI, 1.02–1.41]). Conclusions In the borderline‐high LDL‐C population, those with the lowest RC levels showed no significant risk difference compared with controls, and this pattern remained consistent across different sexes and age subgroups. In the high LDL‐C population, even when RC was at the lowest level, ASCVD risk remained significantly higher than that of controls.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2026) conducted a cohort in Elevated LDL-C and Atherosclerotic Cardiovascular Disease (n=62,816). Elevated LDL-C and remnant cholesterol levels vs. Non-elevated LDL-C controls was evaluated on Atherosclerotic cardiovascular disease (ASCVD) (HR 1.20, 95% CI 1.02-1.41). In participants with high LDL-C (≥4.1 mmol/L), even those with the lowest remnant cholesterol levels had a significantly higher risk of ASCVD compared to controls (HR 1.20; 95% CI 1.02-1.41).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: